🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Nexien BioPharma, Inc. (NXEN)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Nov 18, 2026

Nexien BioPharma Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Nov '26 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20
012453
Market Cap Growth
0%-47.97%-39.49%-24.47%90.11%-45.30%
Enterprise Value
-13453
Last Close Price
0.000.020.040.060.090.05

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Nov '26 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20
PB Ratio
--3.30-9.08-32.16-363.58-413.89

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Nov '26 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20
Debt / Equity Ratio
-0.83-0.86-1.08-1.88-2.39-1.88
Net Debt / Equity Ratio
-0.81-0.85-0.94-0.89-1.08-0.19
Quick Ratio
0.020.010.120.480.460.37
Current Ratio
0.020.010.150.510.650.78
Return on Equity (ROE)
------2058.62%
Return on Assets (ROA)
-655.83%-411.28%-210.72%-469.81%-4769.09%-988.36%
Return on Capital Employed (ROCE)
26.30%43.10%112.10%479.60%13384.90%41423.20%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Nov '26 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20
Earnings Yield
-2679.00%-20.08%-15.81%-16.56%-37.14%-101.41%
Buyback Yield / Dilution
-8.06%-6.19%-7.73%-4.44%-2.76%-5.64%